New drug may attack Alzheimer's underlying cause, study finds

preview_player
Показать описание
More than five million Americans live with Alzheimer's disease. Research coming out from the Alzheimer's Association Conference in Washington looks at an experimental drug, solanezumab. The treatment may attack the underlying cause and slow the devastating illness' progress. Dr. David Agus joins "CBS This Morning" to discuss the effects of the drug.
Рекомендации по теме
Комментарии
Автор

I feel like there are great tension recent days between gayle and rest of this morning show. she used to be great but now she jumps in cuts charlie and nora. thats a bit fucked up i hope they can fix it between themselves or if not replace gayle or something..

mayheamk